The Life Sciences Report: You have just returned from the 63rd annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston (“The Liver Meeting”). I know it took place over five days, but could you briefly talk about the focus?

John Tucker: The AASLD meeting covers a broad range of issues around diseases of the liver—everything from alcoholic liver disease to priority rules for liver transplants to viral hepatitis. It is wide-ranging, but recent developments in the treatment of hepatitis C (HCV) were a major focus, simply because there has been so … [visit site to read more]